Can genetic testing added to health checkups predict disease? Are consumer/DTC genetic tests accurate and worth it?
Genetic testing often added to health checkups uses DNA variants to estimate disease risk. However, for most common diseases, genes are only one of many factors—'higher risk' does not mean you will definitely get the disease, and 'lower risk' does not rule it out. Consumer (DTC) genetic tests are mostly probabilistic and non-diagnostic, often testing only a subset of variants and potentially missing important mutations. Clinically valuable genetic tests (e.g., hereditary cancer testing for those with family history) are ordered by physicians with genetic counseling, unlike 'panel' screenings for healthy individuals. The following is a neutral summary of what it can and cannot do, for informational purposes only, not medical advice.
What do consumer genetic tests measure?
Consumer (DTC) or out-of-pocket genetic tests analyze DNA variants to estimate disease risk, ancestry, carrier status, or drug response (pharmacogenetics):
- Formats range from 'single gene' to SNP chip 'risk' reports, to recent 'polygenic risk scores (PRS)'
- Often packaged as add-ons to premium health checkups
- Key point: Most results are 'probabilistic' risk estimates, not disease diagnoses
Can they predict disease? 'Risk' does not equal 'fate'
For most common, complex diseases, genes are only one of many factors (lifestyle, environment also matter):
- 'Higher risk' does not mean you will definitely get the disease; 'lower risk' or negative does not rule it out
- Most results are probabilistic risk estimates, not sufficient alone for medical decisions
- US CDC, NIH, etc., emphasize these risk reports are not diagnostic tools
Limitations of consumer genetic tests
Consumer genetic tests have several important limitations; results should not be overinterpreted:
- Test only a subset of variants: may miss most clinically significant mutations (e.g., some DTC BRCA reports test only a few specific variants, missing most BRCA mutations)
- False positives/negatives exist; third-party reinterpretation of raw data is error-prone
- US FDA advises: before any medical action, DTC results should be confirmed by clinical-grade testing
- Polygenic risk scores (PRS) are still in research/early stages, with limited individual clinical utility, and accuracy decreases across populations (mostly derived from European data)
Which genetic tests have clinical value?
Genetic testing is not useless—but 'clinically valuable' tests differ from 'panel screenings':
- Valuable scenarios: diagnosis of suspected genetic disorders, hereditary cancer testing for those with significant personal or family history (e.g., BRCA, Lynch syndrome), carrier screening, and specific pharmacogenetic tests
- These are ordered by physicians based on personal/family history with 'genetic counseling', unlike add-on panels for healthy individuals
- International guidelines (e.g., US USPSTF) do not recommend routine BRCA testing for the general population without family history risk
Should you get it? Privacy and neutral perspective
For a general person without symptoms or special family history, the evidence for the benefit of panel-based DTC disease risk genetic testing is limited:
- May cause 'false reassurance' or unnecessary anxiety and follow-up tests
- If clinically indicated (family history, symptoms), it should be done through a physician with genetic counseling; results are probabilistic, lifestyle still matters
- Privacy: Genetic data is highly sensitive personal information. Taiwan currently has no specific 'genetic non-discrimination' law; be aware of concerns about data use in insurance/employment; discuss with qualified professionals before testing
FAQ
Can genetic testing added to health checkups accurately predict whether I will get a certain disease?
Most cannot. For common complex diseases, genes are only one of many factors; 'higher risk' does not mean you will definitely get the disease, and 'lower risk' does not rule it out. Consumer genetic tests are mostly probabilistic risk estimates, not diagnostic tools, and cannot be used alone for medical decisions. If in doubt, discuss with a physician or genetic counselor.
Are consumer (DTC) genetic tests accurate? What are their limitations?
There are many limitations: they often test only a subset of variants, potentially missing most clinically significant mutations (e.g., some DTC BRCA reports test only a few specific variants); there are false positives/negatives; third-party reinterpretation of raw data is error-prone. The US FDA advises that any medical action should be confirmed by clinical-grade testing.
Are polygenic risk scores (PRS) reliable?
PRS are still in research/early stages, validated mainly at the population level, with limited value for individual clinical decisions; they are often derived from European population data, reducing accuracy in other populations. They are 'under investigation/not yet routine' and should not be taken as a definitive personal risk.
So is genetic testing useless?
No. Clinically valuable scenarios include: diagnosis of suspected genetic disorders, hereditary cancer testing for those with significant family history (e.g., BRCA, Lynch syndrome), carrier screening, and specific pharmacogenetic tests. These are ordered by physicians based on personal/family history with genetic counseling, unlike add-on panels for healthy individuals.
For a general person without family history, is it worth paying out-of-pocket for a genetic testing panel?
For a general person without symptoms or special family history, the evidence for the benefit of panel-based disease risk genetic testing is limited; it may cause false reassurance or unnecessary anxiety and follow-up tests. International guidelines do not recommend routine BRCA testing for the general population. Discuss with a physician before deciding, rather than doing it due to marketing.
Are there privacy or insurance concerns with genetic testing?
Yes. Genetic data is highly sensitive personal information. Taiwan currently has no specific 'genetic non-discrimination' law (unlike the US GINA, which also does not cover life insurance, etc.). Concerns about data use in insurance and employment are still under discussion. Before testing, understand how data will be stored and used, and discuss with qualified professionals.
This page is a neutral compilation of information for reference only, not Medical advice, and does not constitute any diagnostic commitment.